Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![raghavwadhwa Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::100281231.png) Raghav Wadhwa [@raghavwadhwa](/creator/twitter/raghavwadhwa) on x 97K followers
Created: 2025-07-17 09:09:32 UTC

🔹Cipla, Dr. Reddy’s Laboratories, Lupin, and Sun Pharma are aggressively advancing generic or novel GLP-1 therapies, with regulatory filings and R&D pipelines targeting both domestic and international markets.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945772849454620958/c:line.svg)

**Related Topics**
[$drreddyns](/topic/$drreddyns)
[dr reddys](/topic/dr-reddys)
[$ciplans](/topic/$ciplans)

[Post Link](https://x.com/raghavwadhwa/status/1945772849454620958)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

raghavwadhwa Avatar Raghav Wadhwa @raghavwadhwa on x 97K followers Created: 2025-07-17 09:09:32 UTC

🔹Cipla, Dr. Reddy’s Laboratories, Lupin, and Sun Pharma are aggressively advancing generic or novel GLP-1 therapies, with regulatory filings and R&D pipelines targeting both domestic and international markets.

XXXXX engagements

Engagements Line Chart

Related Topics $drreddyns dr reddys $ciplans

Post Link

post/tweet::1945772849454620958
/post/tweet::1945772849454620958